Betaseron

MS Patients More Compliant with Medications When Managed by Specialty Pharmacy, According to HealthCore Study Presented at ISPOR

...majority was female. More than one-third of the patients used Avonex as index medication, while others used Copaxone (31 percent), Rebif (17 percent), betaseron (14 percent) and Tysabri (less than 1 percent). About HealthCore HealthCore, based in Wilmington, Del., is the clinical outcomes research sub...

New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes

...esults showed that early and sustained exposure to betaseron in study participants with multiple sclerosis (MS)... study, early initiation and sustained exposure to betaseron were strongly associated with a reduced risk of a ...d the potential for long-term benefits of starting betaseron treatment early and staying on therapy, even after...

Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals

...ts of the BETAPLUS(TM)(b) program that patients on betaseron can sign up for. It was a great relief and allowed...thCare Pharmaceuticals Inc.(1) About Betaseron betaseron (Interferon beta-1b) is indicated for the treatmen...jections, product formulation and patient support. betaseron therapy requires half as many injections as Copaxo...

Betaseron in Medical Technology

Large Study Shows that Presence of Neutralizing Antibodies Did Not Predict Clinical Response to Betaseron Treatment

WAYNE, N.J., April 02, 2007 /PRNewswire/ -- Berlex, Inc., a U.S. affiliate of Bayer Schering Pharma AG, Germany, announced today the results of a retrospective study demonstrating that the presence of neutralizing antibodies (NAbs) that can develop in response to Betaseron(R) (interferon beta-1b) ...

First of Its Kind Data Show: Immediate Treatment of Early MS Patients with Betaseron Significantly Delayed Permanent Disability

Risk to confirmed EDSS progression reduced by 40 percent compared to delayed treatment BOSTON, May 01, 2007 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals announced today new data, which show that immediate initiation(1) of Betaseron(R) (interferon beta-1b) treatment in patients with a first eve...

Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS

...m a continued benefit of initiating treatment with betaseron shortly after the first event.(1) These five-year ... study also demonstrated that early treatment with betaseron had a beneficial effect on cognition that became e...re from the workforce. Patients treated early with betaseron fared better in tests of cognitive function compar...

New Data Presented at WCTRIMS* Supports the Importance of Early and Sustained Treatment with Betaseron(R)

...arlier treatment initiation and longer exposure to betaseron was associated with improved long-term outcomes in...data from the 16-Year Long-Term Follow-up Study of betaseron to investigate the relationship between timing of ...(diagnosed within two years) who were treated with betaseron and assessed every six months using tests to measu...

Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression

...with the disease start an effective treatment like betaseron right away, rather than wait for further clinical ...ated or relapse-related outcomes in the trial. -- betaseron was safe and well-tolerated, with the reporting of...entered the follow-up study elected to receive betaseron treatment, indicating high patient acceptance of ...

Immediate Treatment of Early MS Patients with Betaferon Significantly Delayed Permanent Disability

... years’ follow up of people treated with Betaferon® has shown that it is safe and well tolerated. References *Mark S. Freedman, et al: betaseron in Newly Emerging Multiple Sclerosis for Initial Treatment (BENEFIT): Effects of Immediate vs. Early Onset of Interferon Beta-1b Treatment, American A...

Studies Presented at Neurology Conference Highlight Early Efficacy, Long-Term Tolerability, and High Patient Satisfaction with Betaseron

...after two years. The second study - known as the betaseron 16-Year Long-Term Follow-up (16- Year LTF) Study(3... of MS who had already participated in the pivotal betaseron trial, the results of which led to the drug's approval in 1993. The long-term use of betaseron was associated with a delay of clinically signific...

Annual Meeting of the Consortium of Multiple Sclerosis Centers Focuses on the Challenges of Care and Research in Multiple Sclerosis

... from pharmaceutical intervention. Results showed that prompt initiation of betaseron treatment in patients with a first MS attack was associated with a 40 perce...rly treatment is desirable in MS to avoid or diminish long-term disability. betaseron is approved for the treatment of relapsing forms of MS to reduce the freque...